Market Snapshot

BSE Sensex: 77186.87 0.00%
BSE 500: 36331.82 -0.13%
BSE 200: 11274.71 -0.13%
BSE 100: 25632.82 -0.12%
BSE BANKEX: 65167.77 -0.30%
BSE IT: 27840.91 0.58%
Nifty 50: 24072.75 -0.02%
Nifty 500: 23232.65 -0.13%
Nifty 200: 13928.95 -0.15%
Nifty 100: 25109.2 -0.08%
Nifty Midcap 100: 62686.75 -0.41%
Nifty Small 100: 19336.25 -0.10%
Nifty IT: 28722.6 0.67%
Nifty PSU Bank: 8347.9 -0.46%

News:

AstraZeneca Pharma India gets ...
Wipro Q1 PAT slips 5% QoQ; rev...
Tech Mahindra Q1 PAT rises 28%...
South Indian Bank Q1 PAT rises...
Artefact Projects bags Rs 3-cr...

Medicamen Biotech Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

16 Jul 2026 | 04:14 PM

238.50

1.65 (0.70%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-41.13%

Return (1Y)

Underperformed Nifty 50 by 36.61%
More Volatile

2.75%

Standard Deviation (1Y)

Higher than Nifty 50 by 1.92%
Not so consistent

4/12

Months

underperformed Nifty 50
AxisDirect View

No View

52 Week High-Low

448

212

News & Announcements

Board of Medicamen Biotech recommends final dividend
50 days ago

Board of Medicamen Biotech recommends final dividend

28 - May - 2026 12:00 | 50 days ago

Medicamen Biotech announced that the Board of Directors of the Company at its meeting held on 27 May 2026, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.

Medicamen Biotech consolidated net profit rises 59.50% in the March 2026 quarter

51 days ago

Medicamen Biotech to announce Quarterly Result
56 days ago

Medicamen Biotech to announce Quarterly Result

22 - May - 2026 12:00 | 56 days ago

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 27 May 2026.
Medicamen Biotech consolidated net profit declines 36.89% in the December 2025 quarter
153 days ago

Medicamen Biotech consolidated net profit declines 36.89% in the December 2025 quarter

14 - Feb - 2026 12:00 | 153 days ago

Net profit of Medicamen Biotech declined 36.89% to Rs 2.19 crore in the quarter ended December 2025 as against Rs 3.47 crore during the previous quarter ended December 2024. Sales rose 3.92% to Rs 46.91 crore in the quarter ended December 2025 as against Rs 45.14 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 46.91 45.14 4

OPM % 9.34 14.86 -

PBDT 3.94 6.09 -35

PBT 2.11 3.88 -46

NP 2.19 3.47 -37

Powered by Capital Market - Live News

Price vs Volume

1D
5D
1M
3M
1Y
3Y
5Y
MAX

Stock Trivia

FII shareholding in Medicamen Biotech Ltd has increased by 359.62% since past 3 Months
FII shareholding in Medicamen Biotech Ltd has decreased by -14.94% since past 1 Year
Promoter shareholding in Medicamen Biotech Ltd has decreased by -6.25% since past 1 Year
GovT shareholding in Medicamen Biotech Ltd has decreased by -6.35% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

×

Online trading for clients based in USA and Canada is restricted. You can continue placing orders through mapped dealers offline

OK

vV5.0.0.6-60